The European Directory of Biotechnology Companies offers key market opportunities by providing access to 2,000 biotech companies and 5,000 executives. It assists in pinpointing decision-makers, ...

As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

The directory offers vital insights into 1,000 top global pharmaceutical and biotech companies, featuring key management, business activities, and more. It aids market research, strategic planning, ...

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

Reinforces Trinity Biotech’s growing position as a key player in diabetes care innovation– Senior commercial executives of Trinity Biotech are ...

Across all industries, the total number of companies on track to go public could make this week the most active for IPOs ...

A global pharmaceutical company is moving into Center City next year — and it could be a “game-changing” development for Philly’s biotech scene, a leader in the space says. “We see it as a ...

Agomab Therapeutics and SpyGlass Pharma secured a combined $350 million in two separate initial public offerings on Thursday ...

Department of Economic & Community Development Commissioner Daniel O'Keefe speaks at the BioCT legislative breakfast in New Haven on Jan. 27, 2025. Monday morning's annual legislative breakfast hosted ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

Unprofitable biotech Veradermics, which still needs FDA approval for its hair loss pill, surged on its debut day.